Table 5

Number of studies, patients and their distributions included in each analysis, for the immunocytochemistry technique
ICC ANALYSIS STUDIES PATIENTS TP FP FN TN
CK-19 [31,62,63] 3 230 111 (48.3%) 19 (8.3%) 27 (11.7%) 73 (31.7%)
GAL-3 [31,64-75] 14 1785 581 (33.9%) 103 (6.0%) 104 (6.0%) 927 (54.1%)
HBME-1 [31,62,64,66,74,76,77] 7 3900 1501 (38.5%) 324 (8.3%) 436 (11.2%) 1639 (42.0%)

LEGEND: TP (true-positive), FP (false-positive), FN (false-negative) and TN (true-negative).

de Matos et al.

de Matos et al. Diagnostic Pathology 2012 7:97   doi:10.1186/1746-1596-7-97

Open Data